Inactivated Polio Vaccine
Trials 19 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT01997632 | Nov 2013 → May 2014 | poliomyelitis | University Hospital, Ghent | Completed | No outcome recorded |
| Phase 1 | NCT01048190 | Aug 2008 → Mar 2009 | poliomyelitis | Chinese Academy of Medical Sciences | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00885157 | Apr → Oct 2009 | poliomyelitis | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03169725 | May 2017 → Jan 2019 | poliomyelitis | LG Chem | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT01389687 | Jul 2011 → Jan 2012 | poliomyelitis | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 3 | NCT00348387 | Jun 2006 → Sep 2008 | poliomyelitis | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 3 | NCT00258843 | Nov 2005 → Feb 2006 | poliomyelitis | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 410 trials | ||||||
| Phase 4 | NCT04051736 | Mar → Dec 2018 | — | China National Biotec Group Company Limited | Completed | No outcome recorded |
| Phase 4 | NCT03286803 | Aug 2017 → Apr 2019 | poliomyelitis | Aga Khan University | Unknown | No outcome recorded |
| Phase 4 | NCT02005536 | Dec 2013 → Sep 2014 | poliomyelitis | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 4 | NCT01847872 | Jul 2013 → Apr 2015 | poliomyelitis | London School of Hygiene and Tropical Medicine | Completed | No outcome recorded |
| Phase 4 | NCT01908114 | Jul 2013 → Jul 2017 | poliomyelitis | Aga Khan University | Unknown | No outcome recorded |
| Phase 4 | NCT01475539 | Nov 2011 → May 2013 | poliomyelitis | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 4 | NCT01278433 | Dec 2010 → Dec 2011 | poliomyelitis | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 4 | NCT01244464 | Nov 2010 → Jun 2011 | poliomyelitis | Sanofi | Completed | No outcome recorded |
| Phase 4 | NCT00893906 | May 2009 → Dec 2012 | influenza | PATH | Completed | No outcome recorded |
| Phase 4 | NCT00168662 | Mar 1995 → Jan 2006 | measles | Bandim Health Project | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT00137696 | Jul 2003 → Jul 2004 | poliomyelitis | Centers for Disease Control and Prevention | Completed | No outcome recorded |
| — | NCT00260312 | Aug 2001 → Jan 2003 | — | Pan American Health Organization | Completed | No outcome recorded |
Also used as a comparator or background therapy in 14 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT03614533 Comparator | Dec 2018 → Aug 2019 | typhoid fever | University of Maryland, Baltimore | Completed | No outcome recorded |
| Phase 2 | NCT00604058 Comparator | Jan → Sep 2008 | poliomyelitis | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT06947499 Comparator | May 2025 → Nov 2026 expected | diphtheria, haemophilus infectious disease, hepatitis B virus infection, pertussis +2 | LG Chem | Recruiting | No outcome recorded |
| Phase 2/3 | NCT01810731 Comparator | Apr 2014 | HIV infectious disease, influenza, malaria, poliomyelitis +1 | Centers for Disease Control and Prevention | Withdrawn | No outcome recorded |
| Phase 35 trials | ||||||
| Phase 3 | NCT05163561 Comparator | Jan 2022 → Apr 2023 | poliomyelitis | Serum Institute of India Pvt. Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT05386810 Comparator | Nov 2020 → Oct 2022 | poliomyelitis | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
| Phase 3 | NCT04429295 Comparator | Jun 2020 → Feb 2021 | Rotavirus infection, diphtheria, haemophilus meningitis, hepatitis B virus infection +3 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 3 | NCT01813604 Comparator | Nov 2012 → Nov 2013 | poliomyelitis | Centers for Disease Control and Prevention | Completed | No outcome recorded |
| Phase 3 | NCT00290342 Comparator | Jan 2006 → Jan 2007 | diphtheria, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 45 trials | ||||||
| Phase 4 | NCT04998344 Comparator | Apr 2021 → Dec 2024 | influenza | University of Bergen | Unknown | No outcome recorded |
| Phase 4 | NCT03723837 Comparator | Nov 2018 → Jun 2019 | poliomyelitis | Tribhuvan University Teaching Hospital, Institute Of Medicine. | Completed | No outcome recorded |
| Phase 4 | NCT03202719 Comparator | Nov 2017 → Oct 2019 | poliomyelitis | Centers for Disease Control and Prevention | Completed | No outcome recorded |
| Phase 4 | NCT01680679 Comparator | May 2012 → May 2014 | influenza | University of Colorado, Denver | Completed | No outcome recorded |
| Phase 4 | NCT00934245 Comparator | Sep 2009 → Jul 2012 | influenza | Wayne Sullender, M.D. | Completed | No outcome recorded |
Evidence & citations 12 cited values
Every value below carries the sentence it was read from. 38 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Polio Vaccine | “introduction of inactivated polio vaccine (IPV) in combination with OPV” PMID 28495264 ↗ Jun 201711“Inactivated Polio Vaccine (IPV)” NCT01847872 ↗ |
| Known as | fIPV | “Fractional dose (one-fifth of full intramuscular dose) of inactivated poliovirus vaccine (fIPV) administered intradermally is used as IPV dose-sparing strategy.” PMID 32798224 ↗ Apr 2021 |
| Known as | IMOVAX Polio | “Commercialized IPV based on Salk strain (Imovax Polio). Should be injected by intramuscular three injections in the anterolateral aspect of thigh at 6, 10 and 14 weeks of age.” NCT03169725 ↗7“fractional doses of sanofi pasteur's IMOVAX Polio injected intradermally” NCT00604058 ↗ “sanofi pasteur's IMOVAX Polio injected intradermally” NCT00885157 ↗ |
| Known as | IMOVAX Polio (IPV) vaccine | “IMOVAX Polio (IPV) vaccine” NCT00604058 ↗ |
| Known as | Inactivated Poliomyelitis Vaccine | “Inactivated Poliomyelitis Vaccine (IPV)-(Oral Poliomyelitis Vaccine) (OPV)-OPV (Sequential 1)” NCT01475539 ↗ |
| Known as | inactivated poliovirus vaccine | “A Phase 4, Randomized Trial to Assess the Safety and Immunogenicity of Inactivated Poliovirus Vaccine When Given Concomitantly With Measles and Rubella Combined Vaccine and...” NCT01847872 ↗7“The purpose of this study was to evaluated the effectiveness of inactivated poliovirus vaccine at a vaccine schedule that is commonly used in developing countries.” NCT00260312 ↗ “Inactivated Poliovirus Vaccine - control vaccine produced by Sanofi.” NCT05386810 ↗ “inactivated poliovirus vaccine (IPV)” NCT00934245 ↗ |
| Known as | IPV | “Children born from September 1994 to January 1996 were randomized into two groups receiving either two doses of measles vaccine at 6 and 9 months or one dose of inactivated...” PMID 10342702 ↗ Apr 199911“This was a follow-up study conducted in 2020 assessing changes in levels of type 2 poliovirus-neutralizing antibodies 2 years postimmunization in children who received...” PMID 37368349 ↗ Jan 2024 “will be administered along with inactivated poliovirus vaccine (IPV) on first 3 visits in both cohorts” NCT00137696 ↗ “with either the 2008-09 northern hemisphere IIV3 or an inactivated polio vaccine (IPV).” PMID 30689757 ↗ Oct 2019 “introduction of inactivated polio vaccine (IPV) in combination with OPV” PMID 28495264 ↗ Jun 2017 “Inactivated poliovirus vaccine (IPV) at 14 weeks and 18 months of age” NCT03202719 ↗ “Inactivated poliovirus vaccine (IPV), trivalent” NCT01680679 ↗ “Inactivated Poliovirus Vaccine (IPV)” NCT03614533 ↗ “Inactivated Polio Vaccine (IPV)” NCT03723837 ↗ “Inactivated Polio Vaccine (IPV)” NCT01847872 ↗ “Inactivated polio vaccine (IPV)” NCT00934245 ↗ “inactivated polio vaccine (IPV)” NCT01813604 ↗ |
| Known as | Poliomyelitis Vaccine inactivated | “Poliomyelitis Vaccine (Inactivated), produced by Serum Institute of India Pvt. Ltd., is a sterile suspension of three types of inactivated poliovirus: Type 1 (Mahoney), Type 2...” NCT05163561 ↗ |
| Known as | Sabin IPV | “A domestic Sabin strain-based inactivated poliovirus vaccine (Sabin IPV) was approved by China Food and Drug Administration in 2017” PMID 33810904 ↗ Mar 2021 |
| Known as | SP059 | “The aim of the study is to assess the immunogenicity and safety of SP059 as a three-dose primary and booster vaccination in Japanese infants aged 3 through 68 months.” NCT01389687 ↗1“The aim of the study is to assess the immunogenicity of SP059 (IMOVAX POLIO®: Inactive Poliovirus Vaccine) vaccine against poliovirus and safety after fifth dose.” NCT02005536 ↗ |
| Modality | Vaccine | “inactivated polio vaccine” NCT00137696 ↗ |
| Route | Intramuscular | “0.5 mL, intramuscular (IM)” NCT00258843 ↗ |